Targeted Therapies for Autoimmune Bullous Diseases: Current Status
Kyle T. Amber(Rush University Medical Center), Michael Hertl(Universitätsklinikum Gießen und Marburg), Rüdiger Eming(Philipps University of Marburg), Roberto Maglie(Philipps University of Marburg), Farzan Solimani(Humboldt-Universität zu Berlin)
Cited by 86
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
|Journal of the European Academy of Dermatology and Venereology|2022|247